These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35498896)

  • 1. Blood pressure targets in CKD 2021: the never-ending guidelines debacle.
    Carriazo S; Sarafidis P; Ferro CJ; Ortiz A
    Clin Kidney J; 2022 May; 15(5):845-851. PubMed ID: 35498896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2015 guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension.
    Chiang CE; Wang TD; Ueng KC; Lin TH; Yeh HI; Chen CY; Wu YJ; Tsai WC; Chao TH; Chen CH; Chu PH; Chao CL; Liu PY; Sung SH; Cheng HM; Wang KL; Li YH; Chiang FT; Chen JH; Chen WJ; Yeh SJ; Lin SJ
    J Chin Med Assoc; 2015 Jan; 78(1):1-47. PubMed ID: 25547819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential implications of the 2021 KDIGO blood pressure guideline for adults with chronic kidney disease in the United States.
    Foti KE; Wang D; Chang AR; Selvin E; Sarnak MJ; Chang TI; Muntner P; Coresh J
    Kidney Int; 2021 Mar; 99(3):686-695. PubMed ID: 33637204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure targets for hypertension in people with diabetes mellitus.
    Arguedas JA; Leiva V; Wright JM
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD008277. PubMed ID: 24170669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].
    Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR
    Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Hypertension: Which Goal for Which Patient?
    Jarraya F
    Adv Exp Med Biol; 2017; 956():117-127. PubMed ID: 27722961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for the management of blood pressure in CKD.
    Ruzicka M; Quinn RR; McFarlane P; Hemmelgarn B; Ramesh Prasad GV; Feber J; Nesrallah G; MacKinnon M; Tangri N; McCormick B; Tobe S; Blydt-Hansen TD; Hiremath S
    Am J Kidney Dis; 2014 Jun; 63(6):869-87. PubMed ID: 24725980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension Management in Patients with Chronic Kidney Disease in the Post-SPRINT Era.
    Jung HH
    Electrolyte Blood Press; 2021 Dec; 19(2):19-28. PubMed ID: 35003282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applying the new intensive blood pressure categories to a nondialysis chronic kidney disease population: the Prevalence, Awareness and Treatment Rates in Chronic Kidney Disease Patients with Hypertension in China survey.
    Zheng Y; Tang L; Zhang W; Zhao D; Zhang D; Zhang L; Cai G; Chen X;
    Nephrol Dial Transplant; 2020 Jan; 35(1):155-161. PubMed ID: 30304540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Blood Pressure With the Progression of CKD: Findings From KNOW-CKD Study.
    Lee JY; Park JT; Joo YS; Lee C; Yun HR; Yoo TH; Kang SW; Choi KH; Ahn C; Oh KH; Sung S; Kim SW; Lee J; Han SH;
    Am J Kidney Dis; 2021 Aug; 78(2):236-245. PubMed ID: 33444666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and Tolerability of Nifedipine GITS in Patients with Chronic Kidney Disease and Uncontrolled Hypertension: A Prospective, Multicenter, Observational Study (ADRENAL).
    Lv R; Chen J; Wang H; Wang J; Cheng H; Li R; Li W; Zhang T; Wei L; Chen Q; Huang J; Yu F; Shen S; Wu H; Liu C; Hong F; Liu J; Zhang X; Xiao H; Song W
    Adv Ther; 2021 Sep; 38(9):4771-4785. PubMed ID: 34331258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary on the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in CKD.
    Mann JFE; Chang TI; Cushman WC; Furth SL; Ix JH; Hou FF; Knoll GA; Muntner P; Pecoits-Filho R; Sarnak MJ; Tomson CRV; Craig JC; Tunnicliffe DJ; Howell M; Tonelli M; Cheung M; Earley A; Cheung AK
    Curr Cardiol Rep; 2021 Aug; 23(9):132. PubMed ID: 34398316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of the blood pressure classification in the new 2017 ACC/AHA hypertension guidelines for the prediction of new-onset chronic kidney disease.
    Maeda T; Yoshimura C; Takahashi K; Ito K; Yasuno T; Abe Y; Masutani K; Nakashima H; Mukoubara S; Arima H
    J Hum Hypertens; 2019 Dec; 33(12):873-878. PubMed ID: 31113986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential for overdiagnosis and underdiagnosis because of blood pressure variability: a comparison of the 2017 ACC/AHA, 2018 ESC/ESH and 2019 NICE hypertension guidelines.
    Bell K; Doust J; McGeechan K; Horvath AR; Barratt A; Hayen A; Semsarian C; Irwig L
    J Hypertens; 2021 Feb; 39(2):236-242. PubMed ID: 32773652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the KDIGO Systolic Blood Pressure Target <120 mm Hg for Chronic Kidney Disease Appropriate in Routine Clinical Practice?
    Dasgupta I; Zoccali C
    Hypertension; 2022 Jan; 79(1):4-11. PubMed ID: 34784720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update of the clinical guideline for hypertension diagnosis and treatment in Iran.
    Bagherikholenjani F; Shahidi S; Khosravi A; Mansouri A; Ashoorion V; Sarrafzadegan N; ; ; ;
    Clin Hypertens; 2024 Jun; 30(1):13. PubMed ID: 38822442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chaos of hypertension guidelines for chronic kidney disease patients.
    Castillo-Rodriguez E; Fernandez-Fernandez B; Alegre-Bellassai R; Kanbay M; Ortiz A
    Clin Kidney J; 2019 Dec; 12(6):771-777. PubMed ID: 31807290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients.
    Lee H; Kwon SH; Jeon JS; Noh H; Han DC; Kim H
    Kidney Res Clin Pract; 2022 Jan; 41(1):31-42. PubMed ID: 34974658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood Pressure Targets Achievement According to 2018 ESC/ESH Guidelines in Three European Excellence Centers for Hypertension.
    Tocci G; Presta V; Ferri C; Redon J; Volpe M
    High Blood Press Cardiovasc Prev; 2020 Feb; 27(1):51-59. PubMed ID: 31916207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure control in patients with chronic kidney disease according to office and home blood pressures.
    Chantrel F; Ott J; Dimitrov Y; Babici D; Fourcade J; Hanon O; Achard JM; Jabourek O; Ducher M; Fauvel JP;
    Blood Press Monit; 2020 Oct; 25(5):246-251. PubMed ID: 32842021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.